DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Li XS, Deitelzweig S, Keshishian A. et al.
Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice. A propensity-matched analysis of 76,940 patients.
Thromb Haemost 2017;
117 (06) 1072-1082
We do not assume any responsibility for the contents of the web pages of other providers.